List of Small Molecule Pharmaceuticals Companies in Indiana - 16

Culture Systemsdevelops and deliver high quality natural ingredients for the dairy, nutritional, and food industries. Their product line includes cultures, dairy ingredients, enzymes, functional proteins, as well as contract-based research and production. Their ingredients are used in the food, pharmaceutical, nutritional and agricultural industries.

Pain controlling device

EIG's mission is to develop highly accurate and non-invasive multi-omic molecular testing solutions for complex diseases like cancer. The company has developed a Multi-omic Integration Platform that combines detection of DNA, RNA, protein and metabolite targets into a single assay. This breakthrough approach transforms the field of molecular diagnostics by offering unparalleled accuracy with comprehensive insights for early disease detection. www.earlyisgood.com.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin’s lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

For over 30 years Enzyme Research Laboratories has been manufacturing and distributing a variety of enzymes and cofactors used in basic coagulation research.By constantly striving for products of utmost quality, ERL has earned the trust of coagulation research communities worldwide. ERL is dedicated to serving the research and diagnostic communities by offering a complementary line of monoclonal and polyclonal antibodies.

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19. The company has discovered small bispecific drugs that engage both cytotoxic immune cells and the virus. Binding of the drug to the virus leads to the destruction of the virus by the immune system.

Gate Neurosciences is on a mission to develop a new generation of therapies for the hundreds of millions of people worldwide suffering from neuropsychiatric and cognitive disorders. We are dedicated to advancing novel, safe, and rapid-acting drug mechanisms that address underlying disease biology by enhancing synaptic function, strengthening neuronal connections, and restoring healthy brain signaling. Our approach focuses on precision psychiatry and evidence-driven insights, and is based on learnings from extensive clinical, preclinical, and translational data across thousands of patients with our molecules. By rethinking what’s possible, we’re creating hope for better mental health treatments and better lives.

Grannus is a biotech startup based on the technological discoveries of Notre Dame Scientists Dr. Brian Blagg and Dr. Sanket Mishra, and the administration of pharmaceutical company that has the... Meanwhile, McDonnell has high-profile.

Provides toxicology services, analysis, bioanalysis, drug metabolism and pharmacokinetics (DMPK), and consulting solutions.

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral therapeutics designed to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV)

NĒRx BioSciences Inc is a company dedicated to the discovery and development of targeted therapeutics for cancer. Formed in 2009, we specialize in the discovery and development of targeted therapeutics for cancer.

Neurodon - We began as a team of scientists building upon an established, yet not fully explored, way to approach disease: cellular stress and calcium imbalance in the cell. Cellular stress and calcium imbalance have been shown to be at the root of a wide range of diseases. For years, we have been researching how activating a calcium pump called SERCA in the cell can restore calcium balance and reverse cellular stress. Our breakthrough therapeutics are now under preclinical development for diseases such as diabetes, Alzheimer’s, Parkinson’s, Duchenne muscular dystrophy, and other rare diseases. We have formed impressive partnerships to help achieve our vision of changing the lives of patients suffering from debilitating diseases.

Singota Solutions is a cGMP compliant, FDA registered Contract Development and Manufacturing Organization (CDMO), providing the pharmaceutical industry with formulation development, supply chain and materials management, analytical testing, labeling and kitting services, and aseptic manufacturing. Founded in 2006, and headquartered in Bloomington, Indiana, Singota serves 200+ clients offering them superior, quality driven outsourcing services. The company assists its clients in moving their products from "the bench" to the market with quality, speed, reliability, responsiveness, innovation and transparency. Singota is heavily focused on continuously increasing the efficiencies of its services, thereby reducing drug development process lead-times.

Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform.

Contract research organization specializing in solid-state chemistry. The scientists at Triclinic Labs have the proven experience to help you with the most challenging chemical development, solid-form screening and selection, and intellectual property issues. With our expert organic, physical, and analytical chemistry capabilities we can maximize your development and market and franchise potential. Whether you require rapid materials characterization, IP support during patent prosecution or litigation, solid-form development, or chemical troubleshooting assistance with your pharmaceutical or fine chemical, we have the instrumentation and scientific knowledge to help you reach your goals quickly, thoroughly, and cost effectively. We specialize in: - Solid form screening and development - Crystallization Method Development - Amorphous Material Development - Analytical Method Development, Validation, Release testing - cGMP Materials Characterization - Contaminant, Counterfeit, and Product Failure Analysis - Chemical Intellectual Property Support (Patent Prosecution and Litigation)

Tymora Analytical Operations provides new research services, products, and reagents to the life science R&D organizations. Tymora has developed nanoscale platform technologies – with PolyMAC and pIMAGO as the lead products – for unmet needs in analysis of protein phosphorylation that relates to the onset of numerous diseases, most notably cancer